@FierceMedDev: UPDATED w/ interview: Apollo's minimally invasive intragastric weight-loss balloon shows promise in clinical trial. Story | Follow @FierceMedDev
@VarunSaxena2: ICYMI: Advice for med tech entrepreneurs: Identify your customer and consider stakeholders' incentives carefully. Editor's corner | Follow @VarunSaxena2
@EmilyWFierce: $ILMN filed a patent infringement suit against Ariosa/$RHHBY over prenatal testing tech. Release | Follow @EmilyWFierce
> After its recent FDA approval, Nevro ($NVRO) has filed to raise $75 million in a follow-on and sell $125 million in shares for its stockholders. It raised $126 million in a November IPO. Shares were off 3% in early trading on the news, still, its price has more than tripled since the IPO. More
> TPG Biotech has brought on Heath Lukatch as a partner and managing director; he came from Novo Ventures. He has served as chairman of medical device companies Cianna Medical and Inogen ($INGN). Story
> Medtronic ($MDT) has disclosed its preliminary fourth quarter and fiscal 2015 earnings results. It will hold the call and have final earnings on June 2. More
> GI Dynamics presented data showing that its EndoBarrier gastric liner comes close to achieving improvement similar to gastric bypass surgery in obese patients with type 2 diabetes. More
Biotech News
@FierceBiotech: ICYMI: Novo's liraglutide works in diabetes and obesity. How about NASH? More | Follow @FierceBiotech
@JohnCFierce: Got a few personal notes and saw at least 1 Twitter campaign linked to our "Influentials' list. Check out the report. Feature | Follow @JohnCFierce
> PsiOxus bags $39M from Woodford, GSK for checkpoint inhibitor combo trial. Story
> Intercept plots a big Phase III NASH trial with room for an early approval. Report
> Bluebird beats a path to early approval for its pioneering gene therapy. Article
Pharma News
@FiercePharma: J&J nears $7.5M deal in Risperdal case that could have cost $1.2B. Report | Follow @FiercePharma
@EricPFierce: FDA blesses Baxter saline plant in Spain for shipments to U.S. of 0.9% sodium chloride. FiercePharmaManufacturing story | Follow @EricPFierce
@CarlyHFierce: ICYMI yesterday: Perrigo will talk tie-up if the price is right, CEO says--but Mylan has a ways to go. Report | Follow @CarlyHFierce
> Can Baxalta deliver on its big growth promises? Baxter says yes. More
> Merck KGaA stumbles in Q1 as MS injectable Rebif falls to oral rivals. Report
> Lechleiter takes up Big Pharma's torch to 'debunk' negative myths. Item
Drug Delivery News
> 'Nanosponges' held in place with a hydrogel absorb toxins in MRSA infections. Story
> Study finds testosterone gels and patches safer than injections. More
> Endo to buy Par Pharma for $8B to bulk up in injectables. Item
> Celyad, formerly Cardio3, files for U.S. IPO worth up to $115 million. Article
> FDA approves pediatric version of Treximet to treat migraines. Report
Pharma Manufacturing News
> Pharmaniaga project in Saudi Arabia stalls but others move forward. More
> Janssen gets Rutgers' help in move to continuous manufacturing. Article
> FDA blesses Baxter saline plant in Spain to produce for U.S. More
> J&J donates $6M to Rutgers, which is helping Janssen move to continuous manufacturing. Story
> AstraZeneca says Sweden getting its new $285M biologics plant. Report
Pharma Asia News
> Wockhardt faces long haul on FDA travails, Business Today says. Story
> India's Zydus Cadila has 10 vaccines in development, set to launch next year. More
> India drug IP laws in spotlight again in local Fresenius Kabi-Pfizer case. Article
> Taiwan recalls batches of injectable sodium chloride made by Y.F. Chemical. Report
> Thailand faces pushback from private hospitals on cost claims. Item